Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-13,600
Closed -$252K 4446
2018
Q1
$252K Buy
+13,600
New +$201K ﹤0.01% 3182
2017
Q4
Sell
-108,800
Closed -$1.33M 4239
2017
Q3
$1.33M Buy
108,800
+28,400
+35% +$502K 0.01% 1709
2017
Q2
$1.47M Sell
80,400
-72,000
-47% -$1.33M 0.01% 1595
2017
Q1
$3.23M Sell
152,400
-16,800
-10% -$328K 0.03% 814
2016
Q4
$2.52M Buy
169,200
+90,400
+115% +$1.6M 0.02% 1136
2016
Q3
$1.73M Sell
78,800
-112,000
-59% -$2.49M 0.01% 1382
2016
Q2
$3.78M Buy
190,800
+129,200
+210% +$2.2M 0.03% 833
2016
Q1
$1.05M Buy
61,600
+33,200
+117% +$555K 0.01% 1628
2015
Q4
$581K Sell
28,400
-424,000
-94% -$8.82M ﹤0.01% 2425
2015
Q3
$9.71M Sell
452,400
-214,000
-32% -$4.77M 0.05% 490
2015
Q2
$13.3M Buy
666,400
+220,400
+49% +$3.87M 0.08% 308
2015
Q1
$6.95M Buy
+446,000
New +$6.74M 0.05% 506
2014
Q2
Sell
-4,000
Closed -$41K 4705
2014
Q1
$41K Sell
4,000
-41,200
-91% -$426K ﹤0.01% 4369
2013
Q4
$400K Buy
+45,200
New +$358K ﹤0.01% 2880

Other funds holding DXCM

PEAK6 Group's DXCM Position: Q4 2017 in Review

PEAK6 Group sold out of DexCom (DXCM) in Q4 2017, closing a stake of 232,412 shares — an estimated $2.84M sold.

PEAK6 Group first reported a position in DXCM in Q1 2014 and held it in 9 quarters. The position peaked at $4.85M in Q3 2015. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

  • PEAK6 Group reported no remaining DexCom position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 232,412 DexCom shares in Q4 2017, an estimated $2.84M.
  • PEAK6 Group first reported a position in DexCom in Q1 2014 and held it in 9 quarters.
  • PEAK6 Group's DexCom position peaked at $4.85M in Q3 2015.
  • 273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.